RVC May 2025 Investor Forum & Happy Hour

RVC May 2025 Investor Forum

Hosted at Walker & Dunlop Cherry Creek (2345 E 3rd Ave Suite 300, Floor 3, Denver, CO 80206) or virtual via Zoom

RVC Investor Forums bring together accredited angel investors interested in fast-growing, early-stage companies in Colorado. These forums serve to pool the wisdom, expertise, and capital of many individual angels. At this forum, investor members will hear pitches, and afterwards the founders are excused and investors discuss the merits and risks of each venture. There is no requirement to invest and each investor has an opportunity to indicate interest in following or leading a specific deal. Both new and experienced investor members are welcome at forums -- this is the best way to learn hands-on about angel investing! 

Meeting Agenda:

Welcome and Introductions

3:00pm to 3:15 pm

Deal-in-Play Discussion

3:15pm to 4:00pm

4:00 pm to 5:00pm

Investor Only Discussion

5:00 to 5:30pm

Happy Hour

5:30 to 7:00pm

Presenting Companies

Alphyn is developing novel therapies for severe, common skin diseases using its patent-protected Zabalafin Drug Platform. Its lead candidate, Zabalafin Hydrogel (ZH), completed two successful Phase 2a trials for atopic dermatitis, showing superiority over current drugs by targeting itch, inflammation, and bacteria at all disease stages. ZH is safe for long-term use, with excellent tolerability. A global Phase 2b trial is underway. Zabalafin enables Multi-Target Therapeutics™ that treat complex diseases through multiple mechanisms.

Vaporox (VHT) is an FDA-cleared wound care solution that uses hydrating vapor and concentrated oxygen to promote rapid healing. Ideal for use in skilled nursing facilities and private practice, to reduce bioburden, stimulate tissue growth, and help improve patient outcomes. When used with standard wound care, Vaporox has consistently healed up to 84% of chronic wounds.

To attend this event, you must be accredited: Net worth of at least one million US dollars, not including the value of one’s primary residence, or have made at least $200,000 each year for the last two years [or $300,000 if jointly filing] and have the expectation to make the same amount this year. We do not require a minimum investment.